PARACETAMOL Side Effects

6691598-1 | Blood Potassium Decreased, Liver Disorder, Overdose
on Apr 14, 2010 Female patient from UNITED KINGDOM , 51 years of age, was treated with Paracetamol (View Usage). Patient experienced the following unwanted or unexpected effects: blood potassium decreased, liver disorder, overdose. Paracetamol dosage: . During the same period patient was treated with ZAPONEX (View Zaponex Review and Zaponex Label ). Patient was hospitalized.

6689807-8 | Hypertransaminasaemia
Patient was taking Paracetamol (View Usage). Patient had the following side effects: hypertransaminasaemia on Apr 07, 2010 from GERMANY Additional patient health information: Female patient , 61 years of age, weighting 151.0 lb, was diagnosed with pain in extremity, atrial fibrillation (What is atrial fibrillation?), hyperlipidaemia, prophylaxis against gastrointestinal ulcer, hypertension, chronic obstructive pulmonary disease and. Paracetamol dosage: 1000 Mg, Qd. During the same period patient was treated with FALITHROM (3.0 Mg, Qd) (View Falithrom Review and Falithrom Label ), INEGY (1 Df, Qd) (View Inegy Review and Inegy Label ), CONCOR (7.5 Mg, Bid) (View Concor Review and Concor Label ), PANTOZOL (40 Mg, Bid) (View Pantozol Review and Pantozol Label ), RAMIPRIL (5 Mg, Qd) (View Ramipril Review and Ramipril Label ), DIGITOXIN TAB (0.07 Mg, Qd) (View Digitoxin Tab Review and Digitoxin Tab Label ), SPIRIVA (18 Ug, Qd) (View Spiriva Review and Spiriva Label ). Patient was hospitalized.

6682326-4 | Condition Aggravated, Dehydration, Hypernatraemia, Renal Impairment, Sepsis
Adverse event was reported on Mar 31, 2010 by a Male patient taking Paracetamol (View Usage) (Dosage: 1 G, Qid) was diagnosed with back pain (What is back pain?), prostate cancer (What is prostate cancer?) and. Location: UNITED KINGDOM , 89 years of age, After Paracetamol was administered, patient had the following side effects: condition aggravated, dehydration, hypernatraemia, renal impairment, sepsis (What is sepsis?). During the same period patient was treated with CYPROTERONE ACETATE (View Cyproterone Acetate Review and Cyproterone Acetate Label ), DEXTROSE (View Dextrose Review and Dextrose Label ), GOSERELIN (View Goserelin Review and Goserelin Label ), SODIUM CHLORIDE (View Sodium Chloride Review and Sodium Chloride Label ). Patient was hospitalized.

6678776-2 | Toxic Epidermal Necrolysis
on Mar 31, 2010 Female patient from MOROCCO , 76 years of age, was diagnosed with arthralgia and was treated with Paracetamol (View Usage). Patient experienced the following unwanted or unexpected effects: toxic epidermal necrolysis. Paracetamol dosage: . During the same period patient was treated with CELECOXIB (View Celecoxib Review and Celecoxib Label ), THIOCOLCHICOSIDE (View Thiocolchicoside Review and Thiocolchicoside Label ). Patient was hospitalized.


6672577-7 | Blood Creatinine Increased, Blood Ph Decreased, Circulatory Collapse, Hepatic Failure, International Normalised Ratio Increased, Overdose
on Mar 31, 2010 Female patient from BELGIUM , 31 years of age, was treated with Paracetamol (View Usage). Patient had the following side effects: blood creatinine increased, blood ph decreased, circulatory collapse, hepatic failure, international normalised ratio increased, overdose. Paracetamol dosage: . Patient was hospitalized.

6672545-5 | Chest Discomfort, Depressed Level Of Consciousness, Electrocardiogram Change, Vomiting
Patient was taking Paracetamol (View Usage). After Paracetamol was administered, patient had the following side effects: chest discomfort, depressed level of consciousness, electrocardiogram change, vomiting on Mar 29, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 16 years of age, was diagnosed with intentional overdose and. Paracetamol dosage: . During the same period patient was treated with FLECAINIDE ACETATE (View Flecainide Acetate Review and Flecainide Acetate Label ), CODEINE SULFATE (View Codeine Sulfate Review and Codeine Sulfate Label ). Patient was hospitalized.

6666262-5 | Hepatitis Acute
Adverse event was reported on Mar 30, 2010 by a Male patient taking Paracetamol (View Usage) (Dosage: ) was diagnosed with influenza, allergy to animal and. Location: GERMANY , 28 years of age, Patient experienced the following unwanted or unexpected effects: hepatitis acute. During the same period patient was treated with REACTINE (View Reactine Review and Reactine Label ), GRIPPOCAPS (View Grippocaps Review and Grippocaps Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), SYMBICORT (View Symbicort Review and Symbicort Label ). Patient was hospitalized.

6665519-1 | Orthostatic Hypotension
on Mar 22, 2010 Female patient from UNITED KINGDOM , 66 years of age, was diagnosed with pain (What is pain?), thrombosis prophylaxis and was treated with Paracetamol (View Usage). Patient had the following side effects: orthostatic hypotension. Paracetamol dosage: . During the same period patient was treated with RIVAROXABAN (View Rivaroxaban Review and Rivaroxaban Label ).

6660387-6 | Dehydration, Depressed Level Of Consciousness, Haemodynamic Instability, Hyperglycaemia, Hypotension, Ketonuria, Kussmaul Respiration, Metabolic Acidosis, Nystagmus
on Mar 17, 2010 Male patient from UNITED KINGDOM , 37 years of age, was diagnosed with myocardial ischaemia and was treated with Paracetamol (View Usage). After Paracetamol was administered, patient had the following side effects: dehydration, depressed level of consciousness, haemodynamic instability, hyperglycaemia, hypotension, ketonuria, kussmaul respiration, metabolic acidosis, nystagmus. Paracetamol dosage: 75 G, Qd. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6654982-8 | Hypokalaemia, Liver Injury, Loss Of Consciousness, Tachycardia
Patient was taking Paracetamol (View Usage). Patient experienced the following unwanted or unexpected effects: hypokalaemia, liver injury, loss of consciousness, tachycardia on Mar 15, 2010 from JAPAN Additional patient health information: Female patient , 20 years of age, . Paracetamol dosage: . During the same period patient was treated with IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), EPHEDRINE SUL CAP (View Ephedrine Sul Cap Review and Ephedrine Sul Cap Label ), CAFFEINE (View Caffeine Review and Caffeine Label ), BROMISOVAL (View Bromisoval Review and Bromisoval Label ), ETHENZAMIDE (View Ethenzamide Review and Ethenzamide Label ). Patient was hospitalized.

6648144-8 | Blood Ph Decreased, Circulatory Collapse, Hepatic Failure, Hypotension, International Normalised Ratio Increased, Overdose
Adverse event was reported on Mar 18, 2010 by a Female patient taking Paracetamol (View Usage) (Dosage: ) . Location: BELGIUM , 31 years of age, Patient had the following side effects: blood ph decreased, circulatory collapse, hepatic failure, hypotension, international normalised ratio increased, overdose. Patient was hospitalized.

6645597-6 | Dehydration, Disease Progression, Hypernatraemia, Renal Impairment, Sepsis
on Mar 09, 2010 Male patient from UNITED KINGDOM , 89 years of age, was diagnosed with metastases to spine, back pain (What is back pain?) and was treated with Paracetamol (View Usage). After Paracetamol was administered, patient had the following side effects: dehydration, disease progression, hypernatraemia, renal impairment, sepsis (What is sepsis?). Paracetamol dosage: 1 G, Qid. During the same period patient was treated with CYPROTERONE ACETATE (View Cyproterone Acetate Review and Cyproterone Acetate Label ), DEXTROSE (View Dextrose Review and Dextrose Label ), GOSERELIN (View Goserelin Review and Goserelin Label ), SODIUM CHLORIDE (View Sodium Chloride Review and Sodium Chloride Label ). Patient was hospitalized.

6645596-4 | Condition Aggravated
on Mar 09, 2010 Female patient from UNITED KINGDOM , 66 years of age, was diagnosed with pain (What is pain?), thrombosis prophylaxis and was treated with Paracetamol (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated. Paracetamol dosage: 1 G, Unk. During the same period patient was treated with XARELTO (10 Mg, Unk) (View Xarelto Review and Xarelto Label ).

6645041-9 | Hypokalaemia, Liver Injury, Loss Of Consciousness, Overdose
Patient was taking Paracetamol (View Usage). Patient had the following side effects: hypokalaemia, liver injury, loss of consciousness, overdose on Mar 08, 2010 from JAPAN Additional patient health information: Female patient , 20 years of age, was diagnosed with overdose and. Paracetamol dosage: . During the same period patient was treated with BROMISOVAL (View Bromisoval Review and Bromisoval Label ), ETHENZAMIDE (View Ethenzamide Review and Ethenzamide Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ).

6637625-9 | Orthostatic Hypotension
Adverse event was reported on Mar 05, 2010 by a Female patient taking Paracetamol (View Usage) (Dosage: ) was diagnosed with pain (What is pain?), thrombosis prophylaxis and. Location: UNITED KINGDOM , 66 years of age, After Paracetamol was administered, patient had the following side effects: orthostatic hypotension. During the same period patient was treated with RIVAROXABAN (View Rivaroxaban Review and Rivaroxaban Label ).

6637569-2 | Hypokalaemia, Liver Injury, Loss Of Consciousness, Tachycardia
on Mar 03, 2010 Female patient from JAPAN , 20 years of age, was treated with Paracetamol (View Usage). Patient experienced the following unwanted or unexpected effects: hypokalaemia, liver injury, loss of consciousness, tachycardia. Paracetamol dosage: . During the same period patient was treated with IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), EPHEDRINE SUL CAP (View Ephedrine Sul Cap Review and Ephedrine Sul Cap Label ), CAFFEINE CITRATE (View Caffeine Citrate Review and Caffeine Citrate Label ), BROMISOVAL (View Bromisoval Review and Bromisoval Label ), ETHENZAMIDE (View Ethenzamide Review and Ethenzamide Label ). Patient was hospitalized.

6637553-9 | Hypersensitivity
on Mar 03, 2010 Male patient from GERMANY , 60 years of age, weighting 121.3 lb, was diagnosed with viral upper respiratory tract infection, limb discomfort and was treated with Paracetamol (View Usage). Patient had the following side effects: hypersensitivity. Paracetamol dosage: 500 Mg, Unk. During the same period patient was treated with DICLOFENAC (Unk) (View Diclofenac Review and Diclofenac Label ). Patient was hospitalized.

6631309-9 | Hepatic Failure
Patient was taking Paracetamol (View Usage). After Paracetamol was administered, patient had the following side effects: hepatic failure on Mar 01, 2010 from GERMANY Additional patient health information: Male patient , 67 years of age, weighting 172.0 lb, was diagnosed with bronchitis (What is bronchitis?), chronic obstructive pulmonary disease, hypertension, cystitis noninfective, benign prostatic hyperplasia and. Paracetamol dosage: 1000 Mg, Qd. During the same period patient was treated with CLARITHROMYCIN (500 Mg, Qd) (View Clarithromycin Review and Clarithromycin Label ), VIANI (1 Df, Qd) (View Viani Review and Viani Label ), AARANE (1 Df, Qd) (View Aarane Review and Aarane Label ), KARVEZIDE (50 Mg, Qd) (View Karvezide Review and Karvezide Label ), NIFURANTIN (100 Mg, Qd) (View Nifurantin Review and Nifurantin Label ), TAMSULOSIN HCL (0.4 Mg, Qd) (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ). Patient was hospitalized.

6626861-3 | Hepatic Failure
Adverse event was reported on Mar 01, 2010 by a Male patient taking Paracetamol (View Usage) (Dosage: 1000 Mg, Qd) was diagnosed with bronchitis (What is bronchitis?), chronic obstructive pulmonary disease, hypertension, cystitis noninfective, benign prostatic hyperplasia and. Location: GERMANY , 67 years of age, weighting 172.0 lb, Patient experienced the following unwanted or unexpected effects: hepatic failure. During the same period patient was treated with CLARITHROMYCIN (500 Mg, Qd) (View Clarithromycin Review and Clarithromycin Label ), VIANI (1 Df, Qd) (View Viani Review and Viani Label ), AARANE (1 Df, Qd) (View Aarane Review and Aarane Label ), KARVEZIDE (50 Mg, Qd) (View Karvezide Review and Karvezide Label ), NIFURANTIN (100 Mg, Qd) (View Nifurantin Review and Nifurantin Label ), TAMSULOSIN HCL (0.4 Mg, Qd) (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ). Patient was hospitalized.

6619429-6 | International Normalised Ratio Increased
on Feb 23, 2010 Female patient from UNITED KINGDOM , 74 years of age, was diagnosed with pain (What is pain?), atrial fibrillation (What is atrial fibrillation?) and was treated with Paracetamol (View Usage). Patient had the following side effects: international normalised ratio increased. Paracetamol dosage: 1 G, Qid. During the same period patient was treated with CODEINE SULFATE (Unk) (View Codeine Sulfate Review and Codeine Sulfate Label ), SINTHROME (View Sinthrome Review and Sinthrome Label ). Patient was hospitalized.

6615743-9 | International Normalised Ratio Increased
on Feb 22, 2010 Female patient from UNITED KINGDOM , 74 years of age, was diagnosed with pain (What is pain?), atrial fibrillation (What is atrial fibrillation?) and was treated with Paracetamol (View Usage). After Paracetamol was administered, patient had the following side effects: international normalised ratio increased. Paracetamol dosage: . During the same period patient was treated with CODEINE SULFATE (View Codeine Sulfate Review and Codeine Sulfate Label ), SINTHROME (View Sinthrome Review and Sinthrome Label ). Patient was hospitalized.

6614915-7 | Diarrhoea, Haematemesis, Hepatic Necrosis, Liver Injury, Overdose, Somnolence
Patient was taking Paracetamol (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, haematemesis, hepatic necrosis, liver injury, overdose, somnolence on Feb 19, 2010 from UNITED KINGDOM Additional patient health information: Male patient , weighting 14.00 lb, was diagnosed with pyrexia and. Paracetamol dosage: 0.3 Ml, Unk. Patient was hospitalized.

6611058-3 | Accidental Overdose
Adverse event was reported on Feb 18, 2010 by a Female patient taking Paracetamol (View Usage) (Dosage: ) was diagnosed with accidental overdose and. Location: UNITED KINGDOM , child 2 years of age, Patient had the following side effects: accidental overdose. Patient was hospitalized.

6602800-6 | Acute Hepatic Failure, Hepatic Encephalopathy, Overdose
on Feb 16, 2010 Female patient from UNITED KINGDOM , 35 years of age, was treated with Paracetamol (View Usage). After Paracetamol was administered, patient had the following side effects: acute hepatic failure, hepatic encephalopathy, overdose. Paracetamol dosage: . Patient was hospitalized.

6602799-2 | Acute Hepatic Failure, Hepatic Encephalopathy, Overdose
on Feb 16, 2010 Female patient from UNITED KINGDOM , 53 years of age, was treated with Paracetamol (View Usage). Patient experienced the following unwanted or unexpected effects: acute hepatic failure, hepatic encephalopathy, overdose. Paracetamol dosage: . Patient was hospitalized.

6602772-4 | Hepatic Necrosis, Incorrect Dose Administered
Patient was taking Paracetamol (View Usage). Patient had the following side effects: hepatic necrosis, incorrect dose administered on Feb 15, 2010 from UNITED KINGDOM Additional patient health information: Female patient , child 5 years of age, was diagnosed with viral infection (What is viral infection?) and. Paracetamol dosage: 2 Df, Unk. During the same period patient was treated with BISMUTH SUBSALICYLATE IN OIL INJ (View Bismuth Subsalicylate In Oil Inj Review and Bismuth Subsalicylate In Oil Inj Label ).

6602767-0 | Dehydration, Depressed Level Of Consciousness, Haemodynamic Instability, Hyperglycaemia, Hypotension, Ketonuria, Kussmaul Respiration, Metabolic Acidosis, Nystagmus
Adverse event was reported on Feb 15, 2010 by a Male patient taking Paracetamol (View Usage) (Dosage: 75 G, Qd) was diagnosed with myocardial ischaemia and. Location: UNITED KINGDOM , 37 years of age, After Paracetamol was administered, patient had the following side effects: dehydration, depressed level of consciousness, haemodynamic instability, hyperglycaemia, hypotension, ketonuria, kussmaul respiration, metabolic acidosis, nystagmus. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6602766-9 | Alanine Aminotransferase Increased, Blood Creatinine Increased, Blood Urea Abnormal, Hepatotoxicity, Nephropathy Toxic, Overdose, Prothrombin Time Abnormal, Renal Failure Acute
on Feb 15, 2010 Female patient from UNITED KINGDOM , 42 years of age, was treated with Paracetamol (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, blood creatinine increased, blood urea abnormal, hepatotoxicity, nephropathy toxic, overdose, prothrombin time abnormal, renal failure acute. Paracetamol dosage: 26 G, Qd. Patient was hospitalized.

6602763-3 | Alanine Aminotransferase Abnormal, Blood Creatinine Abnormal, Blood Urea Abnormal, Hepatotoxicity, Nephropathy Toxic, Overdose, Prothrombin Time Abnormal, Renal Failure Acute
on Feb 15, 2010 Male patient from UNITED KINGDOM , 17 years of age, was treated with Paracetamol (View Usage). Patient had the following side effects: alanine aminotransferase abnormal, blood creatinine abnormal, blood urea abnormal, hepatotoxicity, nephropathy toxic, overdose, prothrombin time abnormal, renal failure acute. Paracetamol dosage: 12 G, Qd. Patient was hospitalized.

6602762-1 | Alanine Aminotransferase Abnormal, Blood Creatinine Abnormal, Blood Urea Abnormal, Hepatotoxicity, Nephropathy Toxic, Overdose, Prothrombin Time Abnormal, Renal Failure Acute
Patient was taking Paracetamol (View Usage). After Paracetamol was administered, patient had the following side effects: alanine aminotransferase abnormal, blood creatinine abnormal, blood urea abnormal, hepatotoxicity, nephropathy toxic, overdose, prothrombin time abnormal, renal failure acute on Feb 15, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 34 years of age, . Paracetamol dosage: 30 G, Qd. Patient was hospitalized.

6602761-X | Alanine Aminotransferase Abnormal, Blood Creatinine Abnormal, Blood Urea Abnormal, Hepatotoxicity, Nephropathy Toxic, Overdose, Prothrombin Time Abnormal, Renal Failure Acute
Adverse event was reported on Feb 15, 2010 by a Male patient taking Paracetamol (View Usage) (Dosage: 15 G, Qd) . Location: UNITED KINGDOM , 27 years of age, Patient experienced the following unwanted or unexpected effects: alanine aminotransferase abnormal, blood creatinine abnormal, blood urea abnormal, hepatotoxicity, nephropathy toxic, overdose, prothrombin time abnormal, renal failure acute. Patient was hospitalized.

6602760-8 | Alanine Aminotransferase Increased, Blood Creatinine Increased, Blood Urea Abnormal, Hepatotoxicity, Nephropathy Toxic, Overdose, Prothrombin Time Abnormal, Renal Failure Acute
on Feb 15, 2010 Male patient from UNITED KINGDOM , 39 years of age, was treated with Paracetamol (View Usage). Patient had the following side effects: alanine aminotransferase increased, blood creatinine increased, blood urea abnormal, hepatotoxicity, nephropathy toxic, overdose, prothrombin time abnormal, renal failure acute. Paracetamol dosage: . Patient was hospitalized.

6602759-1 | Alanine Aminotransferase Abnormal, Blood Creatinine Abnormal, Blood Urea Abnormal, Hepatotoxicity, Nephropathy Toxic, Overdose, Prothrombin Time Abnormal, Renal Failure Acute
on Feb 15, 2010 Male patient from UNITED KINGDOM , 30 years of age, was treated with Paracetamol (View Usage). After Paracetamol was administered, patient had the following side effects: alanine aminotransferase abnormal, blood creatinine abnormal, blood urea abnormal, hepatotoxicity, nephropathy toxic, overdose, prothrombin time abnormal, renal failure acute. Paracetamol dosage: 60 G, Qd. Patient was hospitalized.

6602758-X | Alanine Aminotransferase Abnormal, Blood Creatinine Abnormal, Blood Urea Abnormal, Hepatotoxicity, Nephropathy Toxic, Overdose, Prothrombin Time Abnormal, Renal Failure Acute
Patient was taking Paracetamol (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase abnormal, blood creatinine abnormal, blood urea abnormal, hepatotoxicity, nephropathy toxic, overdose, prothrombin time abnormal, renal failure acute on Feb 15, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 61 years of age, . Paracetamol dosage: 24 G, Qd. Patient was hospitalized.

6602756-6 | Amnesia, Confusional State
Adverse event was reported on Feb 15, 2010 by a Female patient taking Paracetamol (View Usage) (Dosage: 1000 Mg, Unk) . Location: UNITED KINGDOM , 64 years of age, weighting 138.9 lb, Patient had the following side effects: amnesia, confusional state. During the same period patient was treated with PHENYLEPHRINE HYDROCHLORIDE (12.2 Mg, Unk) (View Phenylephrine Hydrochloride Review and Phenylephrine Hydrochloride Label ), ADCAL D3 (1 Df, Qd) (View Adcal-d3 Review and Adcal-d3 Label ), ALENDRONIC ACID (70 Mg, 1/week) (View Alendronic Acid Review and Alendronic Acid Label ), ASPIRIN (75 Mg, Qd) (View Aspirin Review and Aspirin Label ), ATENOLOL (12.5 Mg, Qd) (View Atenolol Review and Atenolol Label ), CANDESARTAN (8 Mg, Qd) (View Candesartan Review and Candesartan Label ), FERROUS SULFATE TAB (200 Mg, Bid) (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), GLYCERYL TRINITRATE (1 Df, Prn) (View Glyceryl Trinitrate Review and Glyceryl Trinitrate Label ).

6595401-X | Hepatitis Acute
on Feb 12, 2010 Male patient from GERMANY , 28 years of age, weighting 169.8 lb, was diagnosed with allergy to animal, asthma (What is asthma?) and was treated with Paracetamol (View Usage). After Paracetamol was administered, patient had the following side effects: hepatitis acute. Paracetamol dosage: Unk. During the same period patient was treated with REACTINE, 10 MG, FILMTABL, MCNEIL (10 Mg, Tid) (View Reactine, 10 Mg, Filmtabl, Mcneil Review and Reactine, 10 Mg, Filmtabl, Mcneil Label ), GRIPPOSTAD C, HARTKPS, STADA (2 Df, Tid) (View Grippostad C, Hartkps, Stada Review and Grippostad C, Hartkps, Stada Label ), IBUPROFEN, 200 MG, TABL, (200 Mg, Tid) (View Ibuprofen, 200 Mg, Tabl, Review and Ibuprofen, 200 Mg, Tabl, Label ), SYMBICORT TURBOHALER, 160/4,5 UG, INH (1 Df, Bid) (View Symbicort Turbohaler, 160/4,5 Ug, Inh Review and Symbicort Turbohaler, 160/4,5 Ug, Inh Label ). Patient was hospitalized.

6594800-X | Amnesia, Confusional State
on Feb 11, 2010 Female patient from UNITED KINGDOM , 64 years of age, weighting 138.9 lb, was treated with Paracetamol (View Usage). Patient experienced the following unwanted or unexpected effects: amnesia, confusional state. Paracetamol dosage: . During the same period patient was treated with PHENYLEPHRINE HYDROCHLORIDE (View Phenylephrine Hydrochloride Review and Phenylephrine Hydrochloride Label ), ADCAL D3 (View Adcal-d3 Review and Adcal-d3 Label ), ALENDRONIC ACID (View Alendronic Acid Review and Alendronic Acid Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), CANDESARTAN (View Candesartan Review and Candesartan Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ).

6592761-0 | Hepatotoxicity, Overdose, Renal Failure Acute
Patient was taking Paracetamol (View Usage). Patient had the following side effects: hepatotoxicity, overdose, renal failure acute on Feb 09, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 61 years of age, . Paracetamol dosage: 24 G, Unk. Patient was hospitalized.

6592758-0 | Coagulopathy, Encephalopathy, Hepatitis
Adverse event was reported on Feb 10, 2010 by a Female patient taking Paracetamol (View Usage) (Dosage: 1 G, Qid) was diagnosed with convulsion and. Location: BELGIUM , 60 years of age, weighting 198.4 lb, After Paracetamol was administered, patient had the following side effects: coagulopathy, encephalopathy, hepatitis (What is hepatitis?). During the same period patient was treated with VALPROIC ACID (View Valproic Acid Review and Valproic Acid Label ), CARBAMAZEPINE (View Carbamazepine Review and Carbamazepine Label ), DICLOFENAC (View Diclofenac Review and Diclofenac Label ), MORPHINE (View Morphine Review and Morphine Label ). Patient was hospitalized.

6592757-9 | Hepatic Necrosis, Hepatic Steatosis, Hepatitis, Hepatotoxicity, Liver Transplant, Multi-organ Failure
on Feb 10, 2010 Female patient from BELGIUM , 43 years of age, weighting 154.3 lb, was treated with Paracetamol (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic necrosis, hepatic steatosis, hepatitis (What is hepatitis?), hepatotoxicity, liver transplant (What is liver transplant?), multi-organ failure. Paracetamol dosage: 1 G, Qid. During the same period patient was treated with KETOROLAC TROMETHAMINE (30 Mg, Unk) (View Ketorolac Tromethamine Review and Ketorolac Tromethamine Label ). Patient was hospitalized.

6592702-6 | Hepatotoxicity, Overdose, Renal Failure Acute
on Feb 09, 2010 Female patient from UNITED KINGDOM , 42 years of age, was treated with Paracetamol (View Usage). Patient had the following side effects: hepatotoxicity, overdose, renal failure acute. Paracetamol dosage: 26 G, Unk. Patient was hospitalized.

6592701-4 | Hepatotoxicity, Overdose, Renal Failure Acute
Patient was taking Paracetamol (View Usage). After Paracetamol was administered, patient had the following side effects: hepatotoxicity, overdose, renal failure acute on Feb 09, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 57 years of age, . Paracetamol dosage: 25 G, Unk. Patient was hospitalized.

6592624-0 | Acute Pulmonary Oedema, Hepatic Failure, Overdose, Renal Failure
Adverse event was reported on Feb 08, 2010 by a Female patient taking Paracetamol (View Usage) (Dosage: 30 G, Unk) . Location: FRANCE , 33 years of age, weighting 165.3 lb, Patient experienced the following unwanted or unexpected effects: acute pulmonary oedema, hepatic failure, overdose, renal failure. Patient was hospitalized.

6592623-9 | Hepatic Failure, Overdose, Renal Failure
on Feb 08, 2010 Female patient from FRANCE , 46 years of age, weighting 152.1 lb, was diagnosed with osteoarthritis (What is osteoarthritis?) and was treated with Paracetamol (View Usage). Patient had the following side effects: hepatic failure, overdose, renal failure. Paracetamol dosage: 32 G, Unk. During the same period patient was treated with CODEINE SULFATE (View Codeine Sulfate Review and Codeine Sulfate Label ). Patient was hospitalized.

6592621-5 | Hepatic Failure, Overdose, Renal Failure
on Feb 08, 2010 Female patient from FRANCE , 17 years of age, weighting 123.5 lb, was treated with Paracetamol (View Usage). After Paracetamol was administered, patient had the following side effects: hepatic failure, overdose, renal failure. Paracetamol dosage: 19 G, Unk.

6592614-8 | Hepatotoxicity, Overdose, Renal Failure Acute
Patient was taking Paracetamol (View Usage). Patient experienced the following unwanted or unexpected effects: hepatotoxicity, overdose, renal failure acute on Feb 09, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 39 years of age, . Paracetamol dosage: . Patient was hospitalized.

6589715-7 | Hepatotoxicity, Overdose, Renal Failure Acute
Adverse event was reported on Feb 09, 2010 by a Male patient taking Paracetamol (View Usage) (Dosage: 60 G, Unk) . Location: UNITED KINGDOM , 30 years of age, Patient had the following side effects: hepatotoxicity, overdose, renal failure acute. Patient was hospitalized.

6589714-5 | Hepatotoxicity, Overdose, Renal Failure Acute
on Feb 09, 2010 Female patient from UNITED KINGDOM , 34 years of age, was treated with Paracetamol (View Usage). After Paracetamol was administered, patient had the following side effects: hepatotoxicity, overdose, renal failure acute. Paracetamol dosage: 30 G, Unk. Patient was hospitalized.

6589712-1 | Hepatotoxicity, Overdose, Renal Failure Acute
on Feb 09, 2010 Male patient from UNITED KINGDOM , 27 years of age, was treated with Paracetamol (View Usage). Patient experienced the following unwanted or unexpected effects: hepatotoxicity, overdose, renal failure acute. Paracetamol dosage: 15 G, Unk. Patient was hospitalized.

6589711-X | Hepatotoxicity, Overdose, Renal Failure Acute
Patient was taking Paracetamol (View Usage). Patient had the following side effects: hepatotoxicity, overdose, renal failure acute on Feb 09, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 17 years of age, . Paracetamol dosage: 12 G, Unk. Patient was hospitalized.